MINNEAPOLIS, September 28, 2016 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today that the Company has launched a line of sharps containers for use in healthcare facilities. The Assure SD Sharps Container is designed with safety features to minimize needle sticks and combine cost-effective pricing to provide a valuefilled option to healthcare facilities. Sharps containers are used to dispose of syringes, needles and other sharp devices that may injure healthcare providers and their patients.

“The Assure SD sharps container enhances ARKRAY’s ever-increasing line of diabetes-related products that deliver value to our customers,” said ARKRAY USA President Jonathan Chapman. “ARKRAY is becoming a one-stop shop for people with diabetes and their healthcare providers searching for diabetes-related supplies.”

Diabetes, or diabetes mellitus, is a metabolic type of disease in which affected people have high blood glucose (blood sugar), either because insulin production is inadequate (Type 2), or because the islet cells in the pancreas no longer produce insulin (Type 1, sometimes referred to as juvenile diabetes). People with diabetes typically experience frequent urination, become increasingly thirsty and hungry. The American Diabetes Association estimates that nearly 30 million Americans suffer from either Type 1 or Type 2 diabetes and that 25.9% of American’s 65 years of age or greater have Type 2 diabetes.


About ARKRAY USA, Inc.

ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition. ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology, such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit